Lukas Baumann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lukas Baumann has a total of 205 co-authors. Here are the top co-authors by number of shared publications:
- Gregor Sebastian Reiter
Medical University of Vienna
4 shared publications Stefan Sacu
Department of Ophthalmology and Optometry, Vienna Clinical Trial Center (VTC), Medical University of Vienna, Vienna, Austria
4 shared publications- Lukas D. Sauer
Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany
3 shared publications - Reinhard Told
Affiliation Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
3 shared publications Ursula Schmidt-Erfurth
Department of Ophthalmology and Optometry, Vienna Clinical Trial Center (VTC), Medical University of Vienna, Vienna, Austria
3 shared publications- Ursula Schmidt-Erfurth
Medical University of Vienna
3 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 226, 111836
Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT04194268)
- 22 October 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 226, 111836
Open AccessCarbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT04194268)
- Open Access
- 24 March 2026
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 52 (1)
Interleukin-6 to identify mildly injured patients in the trauma resuscitation room – a clinical feasibility study
Purpose: Overtriage in the trauma resuscitation room (TRR) is often a consequence of admission based solely on trauma mechanism criteria. As interleukin-6 (IL-6) can assess injury severity in critically injured patients, the hypothesis of this study was that IL-6 can differentiate upon admission between mild (Injury Severity Score (ISS) 0–8) and moderate (ISS 9–15) trauma and that the parameter correlates with injury severity in lower injury severity groups (ISS < 16) during the first 24 h. Subsequently, we evaluated the ability to define IL-6 cut-off values with an adequate sensitivity, specificity, and negative predictive value to distinguish between moderate and mild injuries. Methods: Fifty patients admitted to the TRR solely based on trauma mechanism criteria and with an ISS < 16 were included in the study. IL-6 was measured at admission, 1, 6, 12 and 24 h later. Results: Thirty-one patients were mildly injured (ISS 0–8), while nineteen patients sustained moderate injuries (ISS 9–15). IL-6 correlated significantly with ISS at all time points. Moderately injured patients showed significantly higher IL-6 levels than mildly injured patients during the first 6 h. IL-6 levels at admission predicted moderate injuries for the IL-6 cut-off value of 2.9pg/ml with a sensitivity of 0.933, specificity of 0.370 and a negative predictive value of 0.970 resulting in undertriage rates of 6.6% and overtriage rates of 54.8%. Conclusion: The data of this feasibility study indicates that IL-6 has the potential to be employed in clinical workflows for early determination between patients with mild and moderate injuries, who are admitted to TRR based on trauma mechanism criteria to abort as early as possible TRR treatment and therefore free resources immediately while preserving patients’ safety.
- 24 March 2026
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 52 (1)
Open AccessInterleukin-6 to identify mildly injured patients in the trauma resuscitation room – a clinical feasibility study
Purpose: Overtriage in the trauma resuscitation room (TRR) is often a consequence of admission based solely on trauma mechanism criteria. As interleukin-6 (IL-6) can assess injury severity in critically injured patients, the hypothesis of this study was that IL-6 can differentiate upon admission between mild (Injury Severity Score (ISS) 0–8) and moderate (ISS 9–15) trauma and that the parameter correlates with injury severity in lower injury severity groups (ISS < 16) during the first 24 h. Subsequently, we evaluated the ability to define IL-6 cut-off values with an adequate sensitivity, specificity, and negative predictive value to distinguish between moderate and mild injuries. Methods: Fifty patients admitted to the TRR solely based on trauma mechanism criteria and with an ISS < 16 were included in the study. IL-6 was measured at admission, 1, 6, 12 and 24 h later. Results: Thirty-one patients were mildly injured (ISS 0–8), while nineteen patients sustained moderate injuries (ISS 9–15). IL-6 correlated significantly with ISS at all time points. Moderately injured patients showed significantly higher IL-6 levels than mildly injured patients during the first 6 h. IL-6 levels at admission predicted moderate injuries for the IL-6 cut-off value of 2.9pg/ml with a sensitivity of 0.933, specificity of 0.370 and a negative predictive value of 0.970 resulting in undertriage rates of 6.6% and overtriage rates of 54.8%. Conclusion: The data of this feasibility study indicates that IL-6 has the potential to be employed in clinical workflows for early determination between patients with mild and moderate injuries, who are admitted to TRR based on trauma mechanism criteria to abort as early as possible TRR treatment and therefore free resources immediately while preserving patients’ safety.
- 3 February 2026
- Published by The R Foundation
findn: Simulation Based Sample Size Estimation
Estimates the sample size for a test or a trial based on repeated simulation using a model based approach. Implements a method by Maruo et al. (2018) and an extension.
- 3 February 2026
- Published by The R Foundation
findn: Simulation Based Sample Size Estimation
Estimates the sample size for a test or a trial based on repeated simulation using a model based approach. Implements a method by Maruo et al. (2018) and an extension.
- 11 November 2024
- Published by Taylor & Francis in Statistics in Biopharmaceutical Research
- Vol. 17 (3) , 446-456
A Basket Trial Design Based on Power Priors
- 11 November 2024
- Published by Taylor & Francis in Statistics in Biopharmaceutical Research
- Vol. 17 (3) , 446-456
A Basket Trial Design Based on Power Priors
- Open Access
baskexact: An R package for analytical calculation of basket trial operating characteristics
- 12 April 2024
- Published by The R Foundation
basksim: Simulation-Based Calculation of Basket Trial Operating Characteristics
- 12 April 2024
- Published by The R Foundation
basksim: Simulation-Based Calculation of Basket Trial Operating Characteristics
- Open Access
Protocol of a randomised controlled phase II clinical trial investigating PREoperative endoscopic injection of BOTulinum toxin into the sphincter of Oddi to reduce bile leakage after hepatic resection: the PREBOT-II trial
Introduction Bile leakage represents a major cause of morbidity following hepatic resection. Although most patients can be managed non-operatively, this complication requires diagnostics and therapeutic interventions. Preoperative endoscopic injection of botulinum toxin (BTX) into the sphincter of Oddi represents an innovative approach to prevent bile leakage. The aim of the PREBOT-II trial is to generate the first randomised controlled trial data on the safety, feasibility and efficacy of preoperative endoscopic BTX injection into the sphincter of Oddi to prevent bile leakage following hepatic resection. Methods and analysis The PREBOT-II trial is an investigator-initiated, exploratory, multicentre, randomised, controlled, open-label, phase II clinical trial with two parallel study groups. 70 patients scheduled for hepatic resection will be randomised to either the intervention or the control group. Patients of the intervention group will undergo preoperative endoscopic injection of BTX into the sphincter of Oddi 3–10 days before surgery, whereas in the control group only hepatic resection will be performed. The primary endpoint is the occurrence of a postoperative bile leakage within 30 days after hepatic resection according to the definition of the International Study Group of Liver Surgery. The secondary endpoints comprise further postoperative morbidity parameters such as severity of postoperative bile leakage, post-hepatectomy haemorrhage or liver failure, mortality and quality of life up to 3 months after hepatic resection. Safety and feasibility of the procedure will also be recorded. Ethics, funding and dissemination The PREBOT-II trial has been approved by the German Federal Institute for Drugs and Medical Devices (reference number 4044932) and the Ethics Committee of Heidelberg University (reference number AFmu-558/2021). This trial is supported by the German Federal Ministry of Education and Research. The results will be presented at national and international conferences and published in a peer-reviewed journal. Trial registration number DRKS00024061, EudraCT: 2020-006001-35.
Open AccessProtocol of a randomised controlled phase II clinical trial investigating PREoperative endoscopic injection of BOTulinum toxin into the sphincter of Oddi to reduce bile leakage after hepatic resection: the PREBOT-II trial
Introduction Bile leakage represents a major cause of morbidity following hepatic resection. Although most patients can be managed non-operatively, this complication requires diagnostics and therapeutic interventions. Preoperative endoscopic injection of botulinum toxin (BTX) into the sphincter of Oddi represents an innovative approach to prevent bile leakage. The aim of the PREBOT-II trial is to generate the first randomised controlled trial data on the safety, feasibility and efficacy of preoperative endoscopic BTX injection into the sphincter of Oddi to prevent bile leakage following hepatic resection. Methods and analysis The PREBOT-II trial is an investigator-initiated, exploratory, multicentre, randomised, controlled, open-label, phase II clinical trial with two parallel study groups. 70 patients scheduled for hepatic resection will be randomised to either the intervention or the control group. Patients of the intervention group will undergo preoperative endoscopic injection of BTX into the sphincter of Oddi 3–10 days before surgery, whereas in the control group only hepatic resection will be performed. The primary endpoint is the occurrence of a postoperative bile leakage within 30 days after hepatic resection according to the definition of the International Study Group of Liver Surgery. The secondary endpoints comprise further postoperative morbidity parameters such as severity of postoperative bile leakage, post-hepatectomy haemorrhage or liver failure, mortality and quality of life up to 3 months after hepatic resection. Safety and feasibility of the procedure will also be recorded. Ethics, funding and dissemination The PREBOT-II trial has been approved by the German Federal Institute for Drugs and Medical Devices (reference number 4044932) and the Ethics Committee of Heidelberg University (reference number AFmu-558/2021). This trial is supported by the German Federal Ministry of Education and Research. The results will be presented at national and international conferences and published in a peer-reviewed journal. Trial registration number DRKS00024061, EudraCT: 2020-006001-35.
- Open Access
- 30 September 2022
- Published by Springer Nature in Sozial Extra
- Vol. 46 (5) , 328-332
Zur Herstellung von Selbsthilfe-Räumen
Zusammenfassung Der Beitrag diskutiert teilnehmend beobachtete Interaktionsdynamiken in Online-Selbsthilfegruppen zu Zeiten von Corona. Orientiert am Datenmaterial werden von den Teilnehmenden hervorgebrachte „Räume“ entlang der Thematiken „Atmosphäre“, „Gefühle“ und „strategische Aneignung“ vorgestellt. Die Analyse zeigt die Potenziale dialogisch ausgerichteter Begegnungsformate auf, welche eine von Solidarität geprägte Auseinandersetzung mit biographischen Verwundungen eröffnen und die Teilnehmenden als handelnde Subjekte in ihrer Begegnung mit als einschränkend wahrgenommenen sozialen Umweltbedingungen bestärken.
- 30 September 2022
- Published by Springer Nature in Sozial Extra
- Vol. 46 (5) , 328-332
Open AccessZur Herstellung von Selbsthilfe-Räumen
Zusammenfassung Der Beitrag diskutiert teilnehmend beobachtete Interaktionsdynamiken in Online-Selbsthilfegruppen zu Zeiten von Corona. Orientiert am Datenmaterial werden von den Teilnehmenden hervorgebrachte „Räume“ entlang der Thematiken „Atmosphäre“, „Gefühle“ und „strategische Aneignung“ vorgestellt. Die Analyse zeigt die Potenziale dialogisch ausgerichteter Begegnungsformate auf, welche eine von Solidarität geprägte Auseinandersetzung mit biographischen Verwundungen eröffnen und die Teilnehmenden als handelnde Subjekte in ihrer Begegnung mit als einschränkend wahrgenommenen sozialen Umweltbedingungen bestärken.
- Open Access
- 11 June 2022
- Published by Wiley in Pediatric Transplantation
- Vol. 26 (6) , e14328
Timing of reconstruction of the lower urinary tract in pediatric kidney transplant recipients: A CERTAIN multicenter analysis of current practice
Background: Preexistent LUTD are considered a hostile environment, which might negatively impact KTx survival. In such cases, surgical reconstruction of the bladder is required. However, there is still disagreement on the optimal timing of the reconstruction procedure.Methods: This is a multicenter analysis of data from the CERTAIN Registry. Included were 62 children aged 8.18 ± 4.90 years, with LUTD. Study endpoints were the duration of initial posttransplant hospitalization, febrile UTIs, and a composite failure endpoint comprising decline of eGFR, graft loss, or death up to 5 years posttransplant. Outcome was compared to matched controls without bladder dysfunction.Results: Forty‐one patients (66.1%) underwent pretransplant and 14 patients (22.6%) posttransplant reconstruction. Bladder augmentation was performed more frequently in the pretransplant (61%) than in the posttransplant group (21%, p = .013). Outcome in the pre‐ and posttransplant groups and in the subgroups of patients on pretransplant PD with major bladder surgery either pre‐ (n = 14) or posttransplant (n = 7) was comparable. Outcomes of the main study cohort and the matched control cohort (n = 119) were comparable during the first 4 years posttransplant; at year 5, there were more events of transplant dysfunction in the study cohort with LUTD than in controls (p = .03).Conclusions: This multicenter analysis of the current practice of LUTD reconstruction in pediatric KTx recipients shows that pre‐ or posttransplant surgical reconstruction of the lower urinary tract is associated with a comparable 5‐year outcome.
- 11 June 2022
- Published by Wiley in Pediatric Transplantation
- Vol. 26 (6) , e14328
Open AccessTiming of reconstruction of the lower urinary tract in pediatric kidney transplant recipients: A CERTAIN multicenter analysis of current practice
Background: Preexistent LUTD are considered a hostile environment, which might negatively impact KTx survival. In such cases, surgical reconstruction of the bladder is required. However, there is still disagreement on the optimal timing of the reconstruction procedure.Methods: This is a multicenter analysis of data from the CERTAIN Registry. Included were 62 children aged 8.18 ± 4.90 years, with LUTD. Study endpoints were the duration of initial posttransplant hospitalization, febrile UTIs, and a composite failure endpoint comprising decline of eGFR, graft loss, or death up to 5 years posttransplant. Outcome was compared to matched controls without bladder dysfunction.Results: Forty‐one patients (66.1%) underwent pretransplant and 14 patients (22.6%) posttransplant reconstruction. Bladder augmentation was performed more frequently in the pretransplant (61%) than in the posttransplant group (21%, p = .013). Outcome in the pre‐ and posttransplant groups and in the subgroups of patients on pretransplant PD with major bladder surgery either pre‐ (n = 14) or posttransplant (n = 7) was comparable. Outcomes of the main study cohort and the matched control cohort (n = 119) were comparable during the first 4 years posttransplant; at year 5, there were more events of transplant dysfunction in the study cohort with LUTD than in controls (p = .03).Conclusions: This multicenter analysis of the current practice of LUTD reconstruction in pediatric KTx recipients shows that pre‐ or posttransplant surgical reconstruction of the lower urinary tract is associated with a comparable 5‐year outcome.